Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00099801

Enrollment

Unknown

Registered

2004-12-21

Start date

2005-01-31

Completion date

2006-03-31

Last updated

2017-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation

Keywords

Kidney, Transplantation, Rejection, Immunosuppression

Brief summary

The safety and efficacy of FTY720 is being evaluated in patients who receive a kidney transplant.

Interventions

DRUGFTY720

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Patients undergoing their first kidney transplant * Male or female age 18 to 65 years

Exclusion criteria

* Patients in need of second kidney transplant or multi-organ transplants.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026